Cigna Stock Gains 26% in a Year: What Lies Ahead for Investors?
https://www.zacks.com/stock/news/2334211/cigna-stock-gains-26-in-a-year-what-lies-ahead-for-investors?cid=CS-ZC-FT-analyst_blog|price_surge_/_plunge-2334211
Sep 10, 2024 - CI benefits from improved premiums resulting from an extensive customer base. Buyouts and adequate operating cash flows are other tailwinds.
0
Why Cigna (CI) is a Top Value Stock for the Long-Term
https://www.zacks.com/stock/news/2333974/why-cigna-ci-is-a-top-value-stock-for-the-long-term?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_value_score-2333974
Sep 10, 2024 - The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
0
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
https://www.zacks.com/stock/news/2326286/are-you-a-value-investor-this-1-stock-could-be-the-perfect-pick?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_value_score-2326286
Aug 23, 2024 - Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
0
CI Financial Corp. (CIXXF) Q2 2024 Earnings Call Transcript
https://seekingalpha.com/article/4713377-ci-financial-corp-cixxf-q2-2024-earnings-call-transcript?source=feed_sector_transcripts
Aug 10, 2024 - CI Financial Corp. (OTCPK:CIXXF) Q2 2024 Earnings Call Transcript August 8, 2024 9:00 AM ETCompany ParticipantsKurt MacAlpine - Chief Executive OfficerAmit...
0
Encompass Health (EHC) Stock Down 6% Despite Q2 Earnings Beat
https://www.zacks.com/stock/news/2318358/encompass-health-ehc-stock-down-6-despite-q2-earnings-beat?cid=CS-ZC-FT-analyst_blog|earnings_article-2318358
Aug 07, 2024 - Encompass Health's (EHC) Q2 results reflect improved net patient revenue per discharge, partly offset by higher costs. It currently estimates 2024 adjusted EPS within $3.97-$4.22, up from the earlier view of $3.86-$4.11.
0
Can Cigna (CI) Beat Q2 Earnings on Growing Pharmacy Revenues?
https://www.zacks.com/stock/news/2312265/can-cigna-ci-beat-q2-earnings-on-growing-pharmacy-revenues?cid=CS-ZC-FT-analyst_blog|earnings_preview-2312265
Jul 30, 2024 - Cigna's (CI) second-quarter earnings are expected to benefit from rising premiums and pharmacy revenues, partially offset by rising expenses.
0
4 Healthcare Stocks Poised to Beat Q2 Earnings Estimates
https://www.zacks.com/stock/news/2305376/4-healthcare-stocks-poised-to-beat-q2-earnings-estimates?cid=CS-ZC-FT-analyst_blog|earnings_preview_esp-2305376
Jul 19, 2024 - Expanding aging population and the increasing demand for affordable health products are likely to have boosted the performance of healthcare stocks in Q2. CI, UHS, HCA & THC are potential outperformers.
0
Can HCA Healthcare (HCA) Beat Q2 Earnings on Growing Admissions?
https://www.zacks.com/stock/news/2304804/can-hca-healthcare-hca-beat-q2-earnings-on-growing-admissions?cid=CS-ZC-FT-analyst_blog|earnings_preview-2304804
Jul 18, 2024 - HCA Healthcare's (HCA) second-quarter earnings are likely to benefit from improved admissions and payer mix, partially offset by rising operating expenses.
0
Elevance Health's (ELV) Q2 Earnings Beat on Lower Benefit Expense
https://www.zacks.com/stock/news/2303869/elevance-health-s-elv-q2-earnings-beat-on-lower-benefit-expense?cid=CS-ZC-FT-analyst_blog|earnings_article-2303869
Jul 17, 2024 - Elevance Health's (ELV) Q2 results gain on strong product revenue growth in the Carelon business and a reduced overall expense level. Adjusted earnings are reiterated to be at a minimum of $37.20 per share in 2024.
0
Can Elevance Health (ELV) Beat Q2 Earnings on Lower Expenses?
https://www.zacks.com/stock/news/2301144/can-elevance-health-elv-beat-q2-earnings-on-lower-expenses?cid=CS-ZC-FT-analyst_blog|earnings_preview-2301144
Jul 12, 2024 - Elevance Health's (ELV) second-quarter results are likely to be aided by improved product revenues, commercial fee-based membership growth, and lower expenses.
0